News Sentiment

ARCT sentiment intelligence

Arcturus Therapeutics Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 39 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.97 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 31

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-4.3% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Roth MKM Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -4.3% Price reacting lower
Trend fit Trend inactive 0.0% over four weeks
Fair value -62.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 30
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 31
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 7
simplywall.st 5
TradingView 2
Seeking Alpha 2
MarketBeat 2
Moomoo 1
MT Newswires 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 15
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 39